Overview

A single but notable observation has surfaced: telehealth visit growth in mental health and dermatology appears to be outpacing growth in primary care telehealth visits. On its face, this is a narrow empirical claim — a comparison of growth rates across three clinical categories within the broader virtual care landscape. But if it holds up under further scrutiny, it carries implications that extend well beyond a footnote in a utilization report. It suggests that the shape of telehealth adoption is not converging toward a single, generalized model of virtual primary care, but instead fragmenting along the lines of which clinical tasks are inherently more compatible with remote delivery.

This matters because much of the early strategic and capital allocation logic around telehealth — particularly in the 2020-2022 period — was built on the assumption that virtual care would gradually substitute for a meaningful share of the traditional primary care visit. Networks were built, platforms were funded, and reimbursement policy was debated largely on that premise. If the growth data instead shows specialty categories such as dermatology and mental health pulling ahead, it implies a different, more segmented reality: telehealth's durable use cases may be concentrated in domains where the clinical workflow itself is naturally suited to remote or asynchronous interaction, rather than in the broad, exam-dependent domain of general primary care.

The Behavioural Mechanics

To understand why this divergence might be occurring, it helps to separate the three categories by what a clinical encounter actually requires.

Primary care visits frequently depend on physical examination — auscultation, palpation, vital sign measurement, in some cases point-of-care testing — and on longitudinal continuity, where a clinician tracks a patient's condition over time using an accumulated physical record. These are precisely the elements that video-based telehealth struggles to replicate. A virtual visit can triage, counsel, and prescribe, but it cannot substitute for a stethoscope or a blood draw. This structural constraint likely places a ceiling on how much of primary care can be virtualized, regardless of patient or provider willingness.

Dermatology, by contrast, is substantially a visual specialty. Diagnosis frequently proceeds from inspection of a lesion, rash, or growth, a task that can often be performed asynchronously via submitted photographs rather than requiring real-time video interaction at all. This asynchronous, store-and-forward compatibility gives dermatology a structural advantage in telehealth delivery that primary care does not share: the clinical task itself is more portable to a screen.

Mental health care operates under a different but equally favorable logic. Much of psychotherapy and psychiatric follow-up consists of verbal exchange, requiring neither physical contact nor specialized equipment. The format was, in a sense, already "remote-compatible" well before telehealth platforms existed — a phone or video call substitutes reasonably well for an in-person session for many patients. Combine this structural fit with two additional forces plausibly at play — continued destigmatization of seeking mental health care, and a persistent gap between behavioral health demand and in-person clinical capacity — and it is reasonable that mental health telehealth visit growth would outpace primary care.

What the Evidence Actually Supports

It is important to be precise about the strength of this signal. In practical terms, this means the claim should be treated as a hypothesis worth tracking rather than an established market fact.

This is not a criticism of the observation's plausibility — the structural reasoning above is coherent and consistent with how telehealth workflows are generally understood to function across specialties. But plausibility is not the same as confirmation. Until additional, independent sources report a similar pattern, the appropriate posture is attentive monitoring rather than confident strategic pivoting.

Strategic Stakes

Despite the thinness of the current evidence base, the strategic question this observation raises is worth taking seriously precisely because of how much capital and organizational attention has been directed at telehealth as a general-purpose care delivery channel. If growth is in fact concentrating in dermatology and mental health, several downstream questions follow.

First, capital allocation: virtual-care investors and operators who have built broad platforms spanning primary care, urgent care, and specialty care may need to reassess where the durable unit economics actually sit. A platform whose growth is disproportionately driven by dermatology and behavioral health visits has a different margin profile, staffing model, and regulatory exposure than one anchored in general primary care substitution.

Second, product design: the technical requirements for supporting dermatology (image capture, asynchronous review workflows, teledermatology-specific documentation) differ meaningfully from those supporting mental health (session scheduling, therapeutic continuity tools, crisis escalation protocols) and again from primary care (integration with labs, prescribing, referral networks). A platform architecture optimized for one may be poorly suited to the others, and this divergence in growth suggests product roadmaps may benefit from specialty-specific rather than horizontal design priorities.

Third, workforce and network strategy: if mental health telehealth demand is growing fastest partly because of unmet in-person capacity, this points to a supply-side dynamic — a shortage of behavioral health clinicians — that virtual delivery is partially absorbing rather than a pure preference shift. That has implications for how health systems and payers think about workforce planning, since virtual capacity may be masking, rather than resolving, an underlying clinician shortage.

Trajectory

Assuming this pattern is real and persists, the most likely path is continued specialization rather than convergence. Dermatology and mental health telehealth are structurally well suited to remote delivery in ways that are unlikely to reverse — the underlying clinical logic does not depend on transient pandemic-era conditions. Primary care telehealth growth, meanwhile, may plateau at a level determined by the subset of encounters that genuinely do not require physical examination — medication management, follow-up consultations, low-acuity triage — while the exam-dependent core of primary care remains anchored to in-person delivery.

However, this trajectory should be held with appropriate humility given the evidentiary base. A single data point does not establish a trend, and the absence of any time-series signal (the record shows no gap between creation and update) means there is currently no basis for assessing whether this divergence is accelerating, stable, or a short-lived artifact. The prudent analytical posture is to flag this as a candidate structural shift in virtual care delivery, worth active monitoring as further evidence accumulates, while avoiding premature strategic commitments built on it alone.

Conclusion

The signal points to a potentially important reordering of telehealth's clinical center of gravity — away from primary care as the presumed anchor use case, toward specialties where the clinical task itself is more naturally compatible with remote or asynchronous delivery. The underlying structural logic is sound and consistent with how dermatology and mental health care are actually practiced. Organizations across the healthcare and virtual-care ecosystem should treat this as an early, plausible hypothesis meriting continued observation rather than a confirmed shift ready to inform resource allocation.